BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17043312)

  • 61. Kinetically-defined component actions in gene repression.
    Chow CC; Finn KK; Storchan GB; Lu X; Sheng X; Simons SS
    PLoS Comput Biol; 2015 Mar; 11(3):e1004122. PubMed ID: 25816223
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Randomness of spatial distributions of two proteins in the cell nucleus involved in mRNA synthesis and their relationship.
    Noordmans HJ; van der Kraan K; van Driel R; Smeulders AW
    Cytometry; 1998 Nov; 33(3):297-309. PubMed ID: 9822340
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Erratum for Trotter et al., "Glucocorticoid Receptor Transcriptional Activation via the BRG1-Dependent Recruitment of TOP2β and Ku70/86".
    Trotter KW; King HA; Archer TK
    Mol Cell Biol; 2017 Sep; 37(18):. PubMed ID: 28847974
    [No Abstract]   [Full Text] [Related]  

  • 64. Cushing Disease with Glucocorticoid-induced Positive Feedback-A New Subtype of Pituitary Corticotropinomas?
    Tóth M
    J Endocr Soc; 2021 Jun; 5(6):bvab079. PubMed ID: 34061123
    [No Abstract]   [Full Text] [Related]  

  • 65. THE PHYSIOLOGICAL BASIS OF REPRESSION AND DISSOCIATION.
    Gordon RG
    J Neurol Psychopathol; 1929 Oct; 10(38):106-13. PubMed ID: 21611294
    [No Abstract]   [Full Text] [Related]  

  • 66. Mutations in the deubiquitinase gene USP8 cause Cushing's disease.
    Reincke M; Sbiera S; Hayakawa A; Theodoropoulou M; Osswald A; Beuschlein F; Meitinger T; Mizuno-Yamasaki E; Kawaguchi K; Saeki Y; Tanaka K; Wieland T; Graf E; Saeger W; Ronchi CL; Allolio B; Buchfelder M; Strom TM; Fassnacht M; Komada M
    Nat Genet; 2015 Jan; 47(1):31-8. PubMed ID: 25485838
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Genetics of Cushing's syndrome.
    Yaneva M; Vandeva S; Zacharieva S; Daly AF; Beckers A
    Neuroendocrinology; 2010; 92 Suppl 1():6-10. PubMed ID: 20829611
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Recurrent gain-of-function USP8 mutations in Cushing's disease.
    Ma ZY; Song ZJ; Chen JH; Wang YF; Li SQ; Zhou LF; Mao Y; Li YM; Hu RG; Zhang ZY; Ye HY; Shen M; Shou XF; Li ZQ; Peng H; Wang QZ; Zhou DZ; Qin XL; Ji J; Zheng J; Chen H; Wang Y; Geng DY; Tang WJ; Fu CW; Shi ZF; Zhang YC; Ye Z; He WQ; Zhang QL; Tang QS; Xie R; Shen JW; Wen ZJ; Zhou J; Wang T; Huang S; Qiu HJ; Qiao ND; Zhang Y; Pan L; Bao WM; Liu YC; Huang CX; Shi YY; Zhao Y
    Cell Res; 2015 Mar; 25(3):306-17. PubMed ID: 25675982
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease.
    Perez-Rivas LG; Theodoropoulou M; Ferraù F; Nusser C; Kawaguchi K; Stratakis CA; Faucz FR; Wildemberg LE; Assié G; Beschorner R; Dimopoulou C; Buchfelder M; Popovic V; Berr CM; Tóth M; Ardisasmita AI; Honegger J; Bertherat J; Gadelha MR; Beuschlein F; Stalla G; Komada M; Korbonits M; Reincke M
    J Clin Endocrinol Metab; 2015 Jul; 100(7):E997-1004. PubMed ID: 25942478
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes.
    Stratakis CA; Tichomirowa MA; Boikos S; Azevedo MF; Lodish M; Martari M; Verma S; Daly AF; Raygada M; Keil MF; Papademetriou J; Drori-Herishanu L; Horvath A; Tsang KM; Nesterova M; Franklin S; Vanbellinghen JF; Bours V; Salvatori R; Beckers A
    Clin Genet; 2010 Nov; 78(5):457-63. PubMed ID: 20507346
    [TBL] [Abstract][Full Text] [Related]  

  • 71. EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas.
    Fukuoka H; Cooper O; Ben-Shlomo A; Mamelak A; Ren SG; Bruyette D; Melmed S
    J Clin Invest; 2011 Dec; 121(12):4712-21. PubMed ID: 22105169
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.
    Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Genetics of Cushing's disease: an update.
    Perez-Rivas LG; Reincke M
    J Endocrinol Invest; 2016 Jan; 39(1):29-35. PubMed ID: 26208471
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing's syndrome?
    Drougat L; Espiard S; Bertherat J
    Eur J Endocrinol; 2015 Oct; 173(4):M121-31. PubMed ID: 26264719
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome.
    Cao Y; He M; Gao Z; Peng Y; Li Y; Li L; Zhou W; Li X; Zhong X; Lei Y; Su T; Wang H; Jiang Y; Yang L; Wei W; Yang X; Jiang X; Liu L; He J; Ye J; Wei Q; Li Y; Wang W; Wang J; Ning G
    Science; 2014 May; 344(6186):913-7. PubMed ID: 24700472
    [TBL] [Abstract][Full Text] [Related]  

  • 76. P53 gene mutation in an atypical corticotroph adenoma with Cushing's disease.
    Kawashima ST; Usui T; Sano T; Iogawa H; Hagiwara H; Tamanaha T; Tagami T; Naruse M; Hojo M; Takahashi JA; Shimatsu A
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):656-7. PubMed ID: 18771563
    [No Abstract]   [Full Text] [Related]  

  • 77. Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation.
    Karl M; Lamberts SW; Koper JW; Katz DA; Huizenga NE; Kino T; Haddad BR; Hughes MR; Chrousos GP
    Proc Assoc Am Physicians; 1996 Jul; 108(4):296-307. PubMed ID: 8863343
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome.
    Sato Y; Maekawa S; Ishii R; Sanada M; Morikawa T; Shiraishi Y; Yoshida K; Nagata Y; Sato-Otsubo A; Yoshizato T; Suzuki H; Shiozawa Y; Kataoka K; Kon A; Aoki K; Chiba K; Tanaka H; Kume H; Miyano S; Fukayama M; Nureki O; Homma Y; Ogawa S
    Science; 2014 May; 344(6186):917-20. PubMed ID: 24855271
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cushing's syndrome in multiple endocrine neoplasia type 1.
    Simonds WF; Varghese S; Marx SJ; Nieman LK
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):379-86. PubMed ID: 21916912
    [TBL] [Abstract][Full Text] [Related]  

  • 80. ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences.
    Espiard S; Drougat L; Libé R; Assié G; Perlemoine K; Guignat L; Barrande G; Brucker-Davis F; Doullay F; Lopez S; Sonnet E; Torremocha F; Pinsard D; Chabbert-Buffet N; Raffin-Sanson ML; Groussin L; Borson-Chazot F; Coste J; Bertagna X; Stratakis CA; Beuschlein F; Ragazzon B; Bertherat J
    J Clin Endocrinol Metab; 2015 Jun; 100(6):E926-35. PubMed ID: 25853793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.